單核細胞活化檢測市場規模、佔有率和成長分析：按產品類型、單核細胞來源、應用、檢測方法、最終用戶和地區分類－2026-2033年產業預測

2024 年全球單核細胞活化試驗 (MAT) 市場價值為 4.125 億美元，預計到 2025 年將成長至 4.5953 億美元，到 2033 年將成長至 954 萬美元，在預測期（2026-2033 年）內複合年成長率為 11.4%。

全球單核細胞活化檢測 (MAT) 市場主要圍繞體外檢測展開，這些檢測方法用於測量人類單核細胞釋放的細胞激素，是傳統動物試驗方法的替代方案。由於疫苗和生物製藥認證中對非動物安全性評估的監管壓力日益增加，對 MAT 的需求激增。 MAT 最初被生物製藥領域的一些創新公司採用，如今已被納入權威藥典，其信譽度也因此得到鞏固。隨著生物製藥和細胞療法需求的成長，製造商越來越傾向於選擇能夠快速評估熱原的高速 MAT 平台，從而提高生產效率並降低成本。此外，人工智慧的整合進一步提升了 MAT 的準確性和效率，加速了行業應用，促進了創新，並為藥品和醫療設備檢測帶來了顯著效益。

全球單核細胞活化檢測市場促進因素

隨著人們對個人化醫療方法的興趣日益濃厚，檢測實驗室正積極推動單核細胞活化檢測作為免疫反應的關鍵預測指標。臨床醫生尋求可靠的生物標記來製定個人化治療方案並改善患者預後，因此對這類檢測的需求不斷成長。此外，監管機構對精準診斷的支持也刺激了檢測方法研發的投資增加，並促使製造商開發更靈敏的檢測平台。這一趨勢使得單核細胞活化檢測更容易被整合到醫院和生物技術公司的常規流程中，從而推動市場成長，並促進其在各種研究和臨床環境中廣泛應用。

全球單核細胞活化檢測市場的限制因素

由於不同醫療體系的報銷架構存在許多不確定性，全球單核細胞活化檢測市場面臨嚴峻挑戰。保險公司往往優先考慮已建立的生物標記物，導致新檢測項目的資金有限，使得許多醫療機構在明確的保險覆蓋範圍指南訂定之前，對採用單核細胞活化檢測持謹慎態度。此外，由於投資回報難以預測，檢測實驗室也不願投資新技術。因此，推廣進程的延遲阻礙了市場成長，迫使製造商將重點放在宣傳推廣和證據收集上，而非積極推行商業化策略。此外，缺乏標準化的計費代碼進一步加劇了保險報銷的複雜性，導致醫療支出更加謹慎。

全球單核細胞活化檢測市場趨勢

隨著臨床研究和治療監測中對個人化免疫檢測的需求不斷成長，全球單核細胞活化檢測市場正經歷著向個人化免疫分析的顯著轉變。相關人員正擴大將單核細胞活化檢測納入患者分層方案，以提高藥物反應和疾病進展預測的準確性。這種模式轉移的驅動力在於人們日益認知到單核細胞路徑在發炎性疾病中的關鍵作用，以及精準醫療的廣泛發展。因此，實驗室正在擴展其服務範圍，而製造商則在客製化試劑盒以適應各種檢體類型，並簡化全球臨床醫生的工作流程自動化。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

單核細胞活化檢測的全球市場規模：依產品類型分類

• MAT檢測套組
• 試劑和耗材
• 設備/器材
• 軟體和數據分析解決方案

全球單核細胞活化檢測市場規模：依單核細胞來源分類

• 周邊血單核細胞（PBMC）
• Mono Mac 6 (MM6)細胞株
• 其他

單核細胞活化檢測的全球市場規模：按應用領域分類

• 藥品熱原檢測
• 醫療設備的熱原檢測
• 生技藥品和細胞/基因療法的檢測
• 疫苗試驗
• 出於研究目的

單核細胞活化檢測的全球市場規模：依檢測方法分類

• 定量MAT
• 定性MAT

單核細胞活化檢測的全球市場規模：依最終用戶分類

• 製藥和生物技術公司
• 受託研究機構（CRO）
• 合約研發生產組織（CDMO）
• 學術研究機構
• 監管與品管研究所

單核細胞活化檢測的全球市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Merck KGaA
• Charles River Laboratories International Inc
• Thermo Fisher Scientific Inc
• Lonza Group AG
• Sanquin
• MAT Research
• MAT Biotech
• Cellmade Laboratories
• Labor LS SE & Co KG
• BD Biosciences
• Beckman Coulter Inc
• Bio-Rad Laboratories Inc
• Eurofins Scientific SE
• Sartorius AG
• Promega Corporation
• Amsbio
• InvivoGen
• Solvias AG
• Microcoat Biotechnologie GmbH
• R&D Systems Inc

結論與建議

Global Monocyte Activation Test Market size was valued at USD 412.5 Million in 2024 and is poised to grow from USD 459.53 Million in 2025 to USD 9.54 Million by 2033, growing at a CAGR of 11.4% during the forecast period (2026-2033).

The global market for the monocyte activation test (MAT) is centered on an in-vitro assay that measures cytokine release from human monocytes, serving as a replacement for traditional animal testing methods. Demand for MAT has surged due to regulatory pressures for animal-free safety assessments, particularly in vaccine and biologics certification. Initially embraced by a few innovators in the biopharma sector, MAT's credibility was solidified through its inclusion in recognized pharmacopoeias. As the demand for biologics and cell-based therapies rises, manufacturers are increasingly favoring rapid MAT platforms that enable quick pyrogen assessments, which streamlines production and reduces costs. Furthermore, AI integration enhances the accuracy and efficiency of MAT, driving widespread adoption and fostering innovation within the industry, significantly benefiting pharmaceutical and medical device testing.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Monocyte Activation Test market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Monocyte Activation Test Market Segments Analysis

Global monocyte activation test market is segmented by product type, source of monocytes, application, test method, end user and region. Based on product type, the market is segmented into MAT Test Kits, Reagents & Consumables, Instruments & Equipment and Software & Data Analysis Solutions. Based on source of monocytes, the market is segmented into Peripheral Blood Mononuclear Cells (PBMCs), Mono Mac 6 (MM6) Cell Line and Others. Based on application, the market is segmented into Pyrogen Testing of Pharmaceuticals, Pyrogen Testing of Medical Devices, Biologics & Cell and Gene Therapy Testing, Vaccine Testing and Research Applications. Based on test method, the market is segmented into Quantitative MAT and Qualitative MAT. Based on end user, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), Contract Development and Manufacturing Organizations (CDMOs), Academic & Research Institutes and Regulatory & Quality Control Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Monocyte Activation Test Market

The increasing focus on personalized treatment approaches is propelling laboratories to implement monocyte activation testing as a vital predictive measure for immune responses. As clinicians endeavor to find reliable biomarkers for customizing therapeutic strategies and enhancing patient outcomes, the demand for these tests grows. Additionally, regulatory support for precision diagnostics motivates further investment in assay development and spurs manufacturers to create more sensitive testing platforms. This trend facilitates the integration of monocyte activation tests into regular procedures in both hospitals and biotech companies, thereby reinforcing market growth and driving widespread adoption across various research and clinical environments.

Restraints in the Global Monocyte Activation Test Market

The Global Monocyte Activation Test market faces significant constraints due to the uncertainty surrounding reimbursement frameworks in various healthcare systems. Many providers hesitate to adopt monocyte activation assays until clear coverage guidelines are established, as payers tend to favor established biomarkers, diverting funding away from newer tests. This ambiguity leads laboratories to avoid investing in new technologies, given the unpredictable return on investment. Consequently, the slow adoption process stifles market growth, compelling manufacturers to shift their focus toward advocacy and generating evidence instead of pursuing aggressive commercialization strategies. Additionally, the absence of standardized billing codes further complicates reimbursement processes, contributing to a cautious approach in institutional spending.

Market Trends of the Global Monocyte Activation Test Market

The Global Monocyte Activation Test market is witnessing a significant trend towards personalized immuno-profiling, as the demand for individualized immune assessments escalates in clinical research and therapeutic monitoring. Stakeholders are increasingly incorporating monocyte activation testing into patient stratification protocols to enhance predictions of drug response and disease progression. This paradigm shift is fueled by a heightened awareness of monocyte pathways' crucial role in inflammatory disorders and the broader movement towards precision medicine. As a result, laboratories are broadening their service offerings, while manufacturers are customizing kits to accommodate various sample types and streamline workflow automation for clinicians globally.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Monocyte Activation Test Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• MAT Test Kits
• Reagents & Consumables
• Instruments & Equipment
• Software & Data Analysis Solutions

Global Monocyte Activation Test Market Size by Source of Monocytes & CAGR (2026-2033)

• Market Overview
• Peripheral Blood Mononuclear Cells (PBMCs)
• Mono Mac 6 (MM6) Cell Line
• Others

Global Monocyte Activation Test Market Size by Application & CAGR (2026-2033)

• Market Overview
• Pyrogen Testing of Pharmaceuticals
• Pyrogen Testing of Medical Devices
• Biologics & Cell and Gene Therapy Testing
• Vaccine Testing
• Research Applications

Global Monocyte Activation Test Market Size by Test Method & CAGR (2026-2033)

• Market Overview
• Quantitative MAT
• Qualitative MAT

Global Monocyte Activation Test Market Size by End User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations (CROs)
• Contract Development and Manufacturing Organizations (CDMOs)
• Academic & Research Institutes
• Regulatory & Quality Control Laboratories

Global Monocyte Activation Test Market Size & CAGR (2026-2033)

• North America (Product Type, Source of Monocytes, Application, Test Method, End User)
  • US
  • Canada
• Europe (Product Type, Source of Monocytes, Application, Test Method, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Source of Monocytes, Application, Test Method, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Source of Monocytes, Application, Test Method, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Source of Monocytes, Application, Test Method, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanquin
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MAT Research
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MAT Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellmade Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Labor LS SE & Co KG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amsbio
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InvivoGen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Solvias AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microcoat Biotechnologie GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• R&D Systems Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations